Baytex to Divest of U.S. Eagle Ford Assets to Advance Higher-Return Canadian Core Portfolio

Transaction delivers immediate value, strengthens financial position, supports material shareholder returns and accelerates ...

Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today ...